Perinatal management of neonatal congenital complete atrioventricular block: a survey of 5 cases
10.3760/cma.j.issn.2096-2932.2022.04.011
- VernacularTitle:新生儿先天性完全性房室传导阻滞5例
- Author:
Mingqiong ZHENG
1
;
Junyi WANG
Author Information
1. 清华大学第一附属医院儿科，北京 100016
- Keywords:
Arrhythmia;
Infant, newborn;
Congenital complete atrioventricular block
- From:Chinese Journal of Neonatology
2022;37(4):339-342
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To study the diagnosis, treatment and outcome of congenital complete atrioventricular block (CCAVB) in neonates before, during and after delivery and to monitor their growth and development.Methods:From December 2017 to June 2021, clinical data of 5 neonates with CCAVB admitted to the neonatal department of our hospital were analyzed.Results:A total of 3 males and 2 females were included. The diagnosis was established at (24.6±3.6) weeks during the fetus period. The average birth weight was (2 493±551) g and the gestational age was (36.7±1.5) weeks. 4 mothers had autoimmune diseases, with positive antinuclear antibodies, SSA and Ro52. The cause of the remaining 1 neonate was undetermined. 4 neonates received isoproterenol treatment after birth, but the therapeutic effects were unsatisfying. The longest continuous isoproterenol infusion in 1 neonate lasted for 18 d. Permanent pacemakers were implanted during hospitalization in 3 neonates and 2 neonates were implanted within 1 year after birth. 1 neonate died of septic shock following pacemaker pocket infection at 26 d after birth. The other 4 neonates were followed up to 1-year-old after pacemaker implantation and their growth and development were otherwise normal.Conclusions:Most of the mothers of CCAVB neonates have autoimmune diseases. Fetal arrhythmias are often found in the second trimester during pregnancy, but most of the neonates can be delivered near full-term. The effects of drug therapy are poor and pacemakers are necessary.
